Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients - Top-Institutions - MDSpire

Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients

  • By

  • Zhiwen Hai

  • Weihua Yang

  • Azam Ghazi

  • Amalia Buitrago

  • Patricia Marín-García

  • Isabel G Azcárate

  • Alba González-Escalada

  • Nineth Rossi

  • Javier Benítez-Cruz

  • Iván Estévez-Benito

  • Agustín Tortajada

  • José R. Regueiro

  • José M. Bautista

  • Narcisa Martinez-Quiles

  • May 14, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Yale School of Medicine / Yale New Haven Hospital
    Yale School of Medicine / Yale New Haven Hospital

    New Haven, Connecticut

    Key Differentiators

    • Immunology

  • #2

    Icahn School of Medicine at Mount Sinai / Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai / Mount Sinai Hospital

    New York, New York

    Key Differentiators

    • Immunology

  • #3

    University Medical Center Freiburg
    University Medical Center Freiburg

    Freiburg, Germany

    Key Differentiators

    • Immunology

  • #4

    Skåne University Hospital
    Skåne University Hospital

    Lund, Sweden

    Key Differentiators

    • Immunology

Original Source(s)

Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients

  • by Zhiwen Hai, Weihua Yang, Azam Ghazi, Amalia Buitrago, Patricia Marín-García, Isabel G Azcárate, Alba González-Escalada, Nineth Rossi, Javier Benítez-Cruz, Iván Estévez-Benito, Agustín Tortajada, José R. Regueiro, José M. Bautista, Narcisa Martinez-Quiles

  • May 14, 2026

Related Content

“Who’s on Backup?”—Exploring Internal Medicine Residency Backup Coverage Systems: Findings from a National Survey

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update